StockData
Cuprina Holdings (Cayman) LTD logo

Cuprina Holdings (Cayman) LTD (CUPR) company profile

CUPRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 3/30
$1.69+0.01 (+0.60%)

Close on Nov 17, 2026Market cap $12.45MP/E –Yield –

About Cuprina Holdings (Cayman)

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

Cuprina Holdings (Cayman) Limited is a biomedical and wound care company that develops, manufactures, and commercializes products for chronic wound management and skin health. The company operates across two principal segments: chronic wound care products and cosmeceutical products. Its flagship offerings include the MEDIFLY line of medical-grade sterile blowfly larvae bio-dressings for maggot debridement therapy, alongside a specialized range of cosmeceutical formulations. Cuprina serves institutional healthcare providers, including medical centers and hospitals, as well as individual consumers.

The company conducts business activities and maintains corporate subsidiaries in Singapore, Malaysia, mainland China, Hong Kong, and the United States, and also participates in a Middle East joint venture. It operates office premises and facilities in Singapore. The company maintains its principal executive offices and headquarters in Singapore.

Summary of the business section of Cuprina Holdings (Cayman)'s latest annual report, written by StockData.

Company profile

Company

Legal name
Cuprina Holdings (Cayman) LTD
Founded
2019
Headquarters
Singapore, U0
Address
Block 1090, Lower Delta Road, #06-08 169201
Phone
(658) 512-7275
Employees
10, Dec 31, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
E9
Fiscal year ends
December 31
Auditor
Kreit & Chiu CPA LLP, Los Angeles, California

Stock & identifiers

Ticker
CUPR
Exchange
Nasdaq
IPO date
Apr 10, 2025
Shares outstanding
7M, Apr 27, 2026
Filer category
<br>Emerging growth company
Stock splits
1-for-8 reverse, May 27, 2026
SEC CIK
1995704
CUSIP
G2592E110
FIGI
BBG01LW6FTB1
Share class FIGI
BBG01LW6FVX2
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
David Yong Qi QUEKChief Executive Officer, Director3,119,859
Tat Jing CHANChief Financial Officer–
Jimmy Peng Siew LEEDirector5,146,638
Peng Kwang TEODirector5,818,504
Pee Keat KOHDirector–
Natasha Kaur RAINADirector–
Wei Chean NGDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Apr 10, 2025
Exchange
Nasdaq
First trading day
Apr 10, 2025
First-day close
$4.15
Lock-up ends (est.)
Oct 7, 2025

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“of December 31, 2025, we had 10 full-time employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?